Simplify Exchange Traded Funds · net assets $359M · 54 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 99.6% · STIV: 0.4%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $12.3M | $13.8M | $82.7M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $13.8M | $7.89M | $5.63M |
| Net realized gain (non-derivative) | $726K | $-731K | $643K |
| Net unrealized appreciation (non-derivative) | $7.87M | $20.6M | $14.2M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Purecycle Technologies Inc EC | $24.7M | 6.89% |
| United Therapeutics Corp EC | $24.6M | 6.86% |
| Novo Nordisk A/s EC | $24.2M | 6.75% |
| Eli Lilly & Company EC | $21.2M | 5.91% |
| Unitedhealth Group Inc EC | $20.7M | 5.76% |
| Warby Parker Inc EC | $19.6M | 5.46% |
| Johnson & Johnson EC | $19.5M | 5.45% |
| Jazz Pharmaceuticals PLC EC | $16.5M | 4.61% |
| Abbvie Inc EC | $16.2M | 4.52% |
| Biohaven Ltd EC | $15.5M | 4.32% |
| Benitec Biopharma Inc EC | $13.5M | 3.75% |
| Thermo Fisher Scientific Inc EC | $11.6M | 3.23% |
| Align Technology Inc EC | $11.3M | 3.14% |
| 10x Genomics Inc EC | $11.2M | 3.13% |
| Quest Diagnostics Inc EC | $10.5M | 2.94% |
| Gilead Sciences Inc EC | $10.3M | 2.87% |
| Elevance Health Inc EC | $9.78M | 2.73% |
| Danaher Corp EC | $8.16M | 2.28% |
| Amgen Inc EC | $7.6M | 2.12% |
| Cvs Health Corp EC | $7.2M | 2.01% |
| Astrazeneca PLC EC | $6.48M | 1.81% |
| Cardinal Health Inc EC | $6.4M | 1.78% |
| Establishment Labs Holdings Inc EC | $5.19M | 1.45% |
| Vertex Pharmaceuticals Inc EC | $5.19M | 1.45% |
| Eyepoint Inc EC | $5.17M | 1.44% |
| Guardant Health Inc EC | $4.14M | 1.15% |
| Ge Healthcare Technologies Inc EC | $3.33M | 0.93% |
| Intuitive Surgical Inc EC | $2.98M | 0.83% |
| Pacira Biosciences Inc EC | $2.11M | 0.59% |
| Abbott Laboratories EC | $1.86M | 0.52% |
| Edwards Lifesciences Corp EC | $1.69M | 0.47% |
| Dreyfus Trsy Oblig Cash M STIV | $1.57M | 0.44% |
| Insmed Inc EC | $1.44M | 0.40% |
| Tg Therapeutics Inc EC | $1.17M | 0.33% |
| Cooper Companies Inc (the) EC | $945K | 0.26% |
| Agilon Health Inc EC | $903K | 0.25% |
| Stryker Corp EC | $708K | 0.20% |
| Boston Scientific Corp EC | $641K | 0.18% |
| Fulcrum Therapeutics Inc EC | $563K | 0.16% |
| Neurocrine Biosciences Inc EC | $559K | 0.16% |
| Zimmer Biomet Holdings Inc EC | $378K | 0.11% |
| Fluor Corp EC | $327K | 0.09% |
| Icon PLC EC | $260K | 0.07% |
| Teleflex Inc EC | $186K | 0.05% |
| Sarepta Therapeutics Inc EC | $138K | 0.04% |
| Praxis Precision Medicines Inc EC | $125K | 0.03% |
| Veralto Corp EC | $68.1K | 0.02% |
| Bristol-myers Squibb Company EC | $63.4K | 0.02% |
| Regeneron Pharmaceuticals Inc EC | $48.6K | 0.01% |
| Healthequity Inc EC | $36.5K | 0.01% |
| Abivax Sa EC | $29.3K | 0.01% |
| Syndax Pharmaceuticals Inc EC | $17.7K | 0.00% |
| Cypherpunk Technologies Inc EC | $17.1K | 0.00% |
| Embecta Corp EC | $9.55K | 0.00% |
Loading...
